Physicians Weigh Benefits, Hurdles Of ICD Risk Stratification
This article was originally published in The Gray Sheet
Executive Summary
Electrophysiologists hope that new risk stratification tools for sudden cardiac death can help sort out the most appropriate recipients of implantable cardioverter defibrillators, although barriers to adoption remain
You may also be interested in...
Heart Rhythm Society, Doctors Oppose National Coverage Of GE’s MTWA Test
GE Healthcare and Cambridge Heart are squaring off over rival methods of microvolt T-wave alternans testing
Heart Rhythm Society, Doctors Oppose National Coverage Of GE’s MTWA Test
GE Healthcare and Cambridge Heart are squaring off over rival methods of microvolt T-wave alternans testing
T-Wave Alternans ICD Screening May Gain Traction With St. Jude Pact
St. Jude Medical's endorsement of microvolt t-wave alternans testing under a co-marketing agreement with test maker Cambridge Heart will help accelerate adoption of the technology, which guides appropriate defibrillator patient selection, both companies say